Law, ethics and medicine
Ethical and legal acceptability of the use of neuromuscular blockers (NMBs) in connection with abstention decisions in Dutch NICUs: interviews with neonatologists
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Analgesics, sedatives and neuromuscular blockers as part of end-of-life decisions in Dutch NICUs
- End-of-life decisions for children under 1 year of age in the Netherlands: decreased frequency of administration of drugs to deliberately hasten death
- The parents' ability to take care of their baby as a factor in decisions to withhold or withdraw life-prolonging treatment in two Dutch NICUs
- Neonatal deaths: prospective exploration of the causes and process of end-of-life decisions
- The attitudes of neonatal professionals towards end-of-life decision-making for dying infants in Taiwan
- The Groningen Protocol for newborn euthanasia; which way did the slippery slope tilt?
- Dutch experience of monitoring active ending of life for newborns
- Delivery room deaths of extremely preterm babies: an observational study
- End-of-life decision-making for newborns: a 12-year experience in Hong Kong
- Retrospective cohort study of all deaths among infants born between 22 and 27 completed weeks of gestation in Switzerland over a 3-year period